GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (MEX:WST) » Definitions » Accumulated other comprehensive income (loss)

West Pharmaceutical Services (MEX:WST) Accumulated other comprehensive income (loss) : MXN-4,204 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. West Pharmaceutical Services's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was MXN-4,204 Mil.

West Pharmaceutical Services's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (MXN-2,684 Mil) to Dec. 2024 (MXN-5,383 Mil) but then increased from Dec. 2024 (MXN-5,383 Mil) to Mar. 2025 (MXN-4,204 Mil).

West Pharmaceutical Services's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (MXN-3,568 Mil) to Dec. 2023 (MXN-2,441 Mil) but then declined from Dec. 2023 (MXN-2,441 Mil) to Dec. 2024 (MXN-5,383 Mil).


West Pharmaceutical Services Accumulated other comprehensive income (loss) Historical Data

The historical data trend for West Pharmaceutical Services's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Accumulated other comprehensive income (loss) Chart

West Pharmaceutical Services Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,200.06 -3,274.03 -3,567.77 -2,440.90 -5,382.86

West Pharmaceutical Services Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,191.46 -3,973.63 -2,683.79 -5,382.86 -4,204.16

West Pharmaceutical Services Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


West Pharmaceutical Services Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services Headlines

From GuruFocus